Lung cancer epidemiology: Contemporary and future challenges worldwide, Ann. Transl. Med, 2016. ,
Cancer Statistics, CA Cancer J. Clin, vol.67, pp.7-30, 2017. ,
Global Cancer in Women: Burden and Trends, Cancer Epidemiol. Biomark. Prev, vol.26, pp.444-457, 2017. ,
Next-Generation Sequencing of Lung Cancers: Lessons Learned and Future Directions, Hematol. Oncol. Clin. North Am, vol.31, pp.1-12, 2017. ,
Molecular pathology of lung cancer: Current status and perspectives, Curr. Opin. Oncol, vol.30, pp.69-76, 2018. ,
Lung cancer as a paradigm for precision oncology in solid tumours, Virchows Arch, vol.471, pp.221-233, 2017. ,
Next generation predictive biomarkers for immune checkpoint inhibition, Cancer Metastasis Rev, vol.36, pp.179-190, 2017. ,
Genomic Testing in Lung Cancer: Past, Present, and Future, J. Natl. Compr. Cancer Netw, vol.16, pp.323-334, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02143584
Risk factors of Lung Cancer in nonsmoker, Curr. Probl. Cancer, vol.41, pp.328-339, 2017. ,
European Respiratory Society Environment and Health Committee Current and new challenges in occupational lung diseases, Eur. Respir. Rev, vol.26, 2017. ,
Biobanking: The foundation of personalized medicine, Curr. Opin. Oncol, vol.23, pp.112-119, 2011. ,
Human tissue biobanks as instruments for drug discovery and development: Impact on personalized medicine, Biomark. Med, vol.4, pp.895-903, 2010. ,
The detection and prevention of errors in laboratory medicine, Ann. Clin. Biochem, vol.47, pp.101-110, 2010. ,
The Economics of Reproducibility in Preclinical Research, PLoS Biol, vol.13, 2015. ,
Tumor biobanks in translational medicine, J. Transl. Med, vol.10, 2012. ,
Tumor biobank as fundamental bio-resource for RNA analysis technologies, vol.29, pp.106-107, 2017. ,
Individual Investigator Profiles of Biospecimen Use in Cancer Research, Biopreserv. Biobank, vol.12, pp.192-198, 2014. ,
The accreditation of a surgical pathology and somatic genetic laboratory (LPCE, CHU of Nice) according to the ISO 15189 norm: Sharing of experience, Ann. Pathol, vol.33, pp.386-397, 2013. ,
Quality assurance in cancer biobanking, Biopreserv. Biobank, vol.9, pp.157-163, 2011. ,
Liquid biopsy and therapeutic targets: Present and future issues in thoracic oncology, Cancers, vol.9, 2017. ,
Liquid biopsy for early detection of lung cancer, Curr. Opin. Oncol, vol.29, pp.73-78, 2017. ,
Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?, Ann. Transl. Med, 2014. ,
IASLC Statement Paper: Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC), J. Thorac. Oncol, 2018. ,
Expression of a truncated active form of VDAC1 in lung cancer associates with hypoxic cell survival and correlates with progression to chemotherapy resistance, Cancer Res, vol.72, pp.2140-2150, 2012. ,
A Comparative and Integrative Approach Identifies ATPase Family, AAA Domain Containing 2 as a Likely Driver of Cell Proliferation in Lung Adenocarcinoma, Clin. Cancer Res, vol.18, pp.5606-5616, 2012. ,
EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: Implications for anti-EGFR treatment of a rare lung malignancy, Int. J. Cancer, vol.125, pp.2479-2482, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00435717
LG Investigators Genomic aberrations in lung adenocarcinoma in never smokers, PLoS ONE, vol.5, 2010. ,
Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: Comparison of the efficacy of the CellSearch Assay ? and the isolation by size of epithelial tumor cell method, Int. J. Cancer, vol.129, pp.1651-1660, 2011. ,
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma, Ann. Oncol, vol.23, pp.1738-1743, 2012. ,
Usefulness of tissue microarrays for assessment of protein expression, gene copy number and mutational status of EGFR in lung adenocarcinoma, Virchows Arch, vol.457, pp.483-495, 2010. ,
High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer, Br. J. Cancer, vol.102, pp.1627-1635, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00497438
Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms, PLoS ONE, vol.12, 2017. ,
Use of the 22C3 anti-programmed death-ligand 1 antibody to determine programmed death-ligand 1 expression in cytology samples obtained from non-small cell lung cancer patients, Cancer Cytopathol, vol.126, pp.264-274, 2018. ,
Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients, Oncotarget, vol.8, pp.26112-26121, 2017. ,
Specificities of Lung Adenocarcinoma in Women Who Have Never Smoked, J. Thorac. Oncol, vol.8, pp.923-929, 2013. ,
Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis, Int. J. Cancer, vol.128, pp.1614-1623, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00497435
miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity, Cell Death Differ, vol.18, pp.465-478, 2011. ,
Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators, Eur. J. Cancer, vol.51, pp.1897-1903, 2015. ,
Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC, PLoS ONE, vol.8, 2013. ,
ALK-gene rearrangement: A comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma, Ann. Oncol, vol.23, pp.2907-2913, 2012. ,
Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer, Cancer, vol.118, pp.1726-1737, 2012. ,
Response of CAIX and CAXII to in vitro re-oxygenation and clinical significance of the combined expression in NSCLC patients, Lung Cancer, vol.82, pp.16-23, 2013. ,
Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients, Ann. Oncol, vol.24, pp.742-748, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01701142
Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps, Cancer Med, vol.4, pp.201-211, 2015. ,
Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer, Ann. Oncol, vol.29, pp.193-199, 2018. ,
Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer, Br. J. Cancer, vol.110, pp.1236-1243, 2014. ,
Publication of biological samples collections catalogues by tumor banks, Bull. Cancer, vol.97, pp.181-189, 2010. ,
Rythmic-pathology: The French national pathology network for thymic epithelial tumours, Ann. Pathol, vol.34, pp.87-91, 2014. ,
, Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking, vol.15, pp.270-276, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01744441
The French mesothelioma network from, Ann. Pathol, vol.34, pp.51-63, 1998. ,
, Biopreserv. Biobank, vol.9, pp.5-6, 2011.
Training the Next Generation of Biobankers: A Two-Year Master's Course in the Management of Biobanks, Biopreserv. Biobank, vol.15, pp.438-450, 2017. ,
French Biobank Secures Specimens, p.17, 2018. ,
, Les missions d'enseignement, de recherche, de référence et d'innovation-MERRI, p.15, 2018.
Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA, Cancers, vol.10, 0195. ,
URL : https://hal.archives-ouvertes.fr/hal-01835099
, The role of the pathologist in tissue banking: European Consensus Expert Group Report. Virchows Arch, vol.456, pp.449-454, 2010.
Public-private relationships in biobanking: A still underestimated key component of open innovation, Virchows Arch, vol.464, pp.3-9, 2014. ,
Biobanking in a Fast Moving World: An International Perspective, JNCI Monogr, pp.50-51, 2011. ,
The evolution of biobanking best practices, Clin. Chim. Acta, vol.413, pp.1569-1575, 2012. ,
The Importance of Biobanking in Cancer Research, Biopreserv. Biobank, vol.13, pp.172-177, 2015. ,
Use Correlates with Emerging Techniques in Cancer Research: Impact on Planning Future Biobanks, Biopreserv. Biobank, vol.10, pp.518-525, 2012. ,
Biospecimen use in cancer research over two decades, Biopreserv. Biobank, vol.8, pp.89-97, 2010. ,
Expert Group on cost recovery in biobanks Public biobanks: Calculation and recovery of costs, Sci. Transl. Med, vol.6, 2014. ,
, Cost Model for Biobanks. Biopreserv. Biobank, vol.11, pp.272-277, 2013.
Group The role of a bioresource research impact factor as an incentive to share human bioresources, Nat. Genet, vol.43, pp.503-504, 2011. ,
Quantifying the use of bioresources for promoting their sharing in scientific research, Gigascience, vol.2, issue.7, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00823375
The Nice CHU biobank experience to collect patients' informed consent for research context, Ann. Pathol, vol.30, p.22, 2004. ,
Measuring the contribution of tumor biobanks to research in oncology: Surrogate indicators and bibliographic output, Biopreserv. Biobank, vol.11, pp.235-244, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-01978789
A practical approach to clinical and research biobanking, Methods Mol. Biol, vol.1180, pp.137-162, 2014. ,
Preanalytical variables affecting the integrity of human biospecimens in biobanking, Clin. Chem, vol.61, pp.914-934, 2015. ,
Storage of human biospecimens: Selection of the optimal storage temperature, Biopreserv. Biobank, vol.12, pp.165-175, 2014. ,
Impact of warm ischemia on gene expression analysis in surgically removed biosamples, Anal. Biochem, vol.423, pp.229-235, 2012. ,
Biopsies: Next-generation biospecimens for tailoring therapy, Nat. Rev. Clin. Oncol, vol.10, pp.437-450, 2013. ,
Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine, Mod. Pathol, vol.26, pp.1413-1424, 2013. ,
Intravital biobank and personalized cancer therapy: The correlation with omics, Int. J. Cancer, vol.135, pp.1511-1516, 2014. ,
Digital pathology and image analysis augment biospecimen annotation and biobank quality assurance harmonization, Clin. Biochem, vol.47, pp.274-279, 2014. ,